chartexchange

ACUR
ACURA PHARMS INC
stockOTC

EODNov 17, 2026
0.0003USD0.000%(0.00)200
Loading…
Loading…
Healthcare
Drug Manufacturers-Specialty & Generic
CEO
Robert Jones
HQ
Palatine, IL, USA
Previous Close
$0.00
Beta
137.04
52-Week High
$0.01 2026-03-19
52-Week Low
$0.00 2026-07-08
SMA 50
$0.00
SMA 200
$0.00
Avg. Vol 10D
8,030
Avg. Vol 30D
4,151
Avg. Vol 90D
7,730
Relative Vol
0.05
64.20M
Aug 28, 2015 · 1-for-5 (reverse)
ACUR Profile

acura pharmaceuticals, inc. is a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and products intended to address medication abuse and misuse. we have discovered and developed three proprietary technology platforms to address abuse and misuse across multiple fronts. • limitx™ technology is designed to retard the release of active drug ingredients when an excess number of tablets are ingested. in 2014, we were awarded a $300,000 grant from the national institute on drug abuse to advance early stage development of our limitx technology. • aversion® technology is a patented composition of commonly used active and inactive pharmaceutical ingredients providing abuse deterrent features to discourage common methods of pharmaceutical product misuse and abuse while providing effective pain relief. oxaydo® tablets (oxycodone hcl, cii), is the first approved product using aversion® in the united states. on january 7, 2015, we entered int

ACUR Performance
PeriodPriceDateChangeBeta
1M0.002026-10-20+200.00%-7.217
3M0.002026-08-19+200.00%-2.078
6M0.002026-05-14+50.00%224.492
1Y0.002025-11-18+50.00%137.044
2Y0.002024-11-20-82.35%—
5Y0.532021-11-19-99.94%-9.212
ACUR Stock Summary

ACURA PHARMS INC (OTC:ACUR) stock price today is $0.00, and today's volume is 200. ACUR is up 0.000% today. The 30 day average volume is 4,151. ACUR market cap is $19,905 with 66.35M shares outstanding.